Paragon Care Limited (FRA:PXS)

Market Cap	130.28M -65.6%
Revenue (ttm)	2.08B +8.5%
Net Income	-7.91M
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	8.46
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0665
Previous Close	0.0715
Day's Range	0.0665 - 0.0665
52-Week Range	0.0665 - 0.2120
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 4, 2026

About Paragon Care

Paragon Care Limited distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia. The company designs, manufactures, and distributes reagent red blood cells, monoclonal blood grouping reagents, and ancillary products for immunohematology laboratories; offers ophthalmology and optometry, neonatal vision screening solutions, and procedural kits. It also provides neonatal and paediatric assessment, including newborn hearing and vision screening, jaundice management, NICU video monitoring, brain monitoring, b...

• Industry: Specialty Cleaning, Polishing, and Sanitation Preparations
• CEO: Carmen Riley
• Employees: 550
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: PXS

Financial Performance

In fiscal year 2025, Paragon Care's revenue was 3.61 billion, an increase of 21.68% compared to the previous year's 2.97 billion. Earnings were 20.57 million, an increase of 151.52%.

Financial numbers in AUD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jun 26, 2026

Data Sources Report a data error